ConductScience.org, home

Paper · 41008607

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139256379Entorhinal cortex vulnerability to human APP expression promotes hyperexcitability and tau pathology.Nat Commun2024https://conductscience.org/library/papers/39256379PubMed
228733960A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood.Neurol Ther2017https://conductscience.org/library/papers/28733960PubMed
332720099Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline.Acta Neuropathol2020https://conductscience.org/library/papers/32720099PubMed
435882228Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer's disease.Neuron2022https://conductscience.org/library/papers/35882228PubMed
536996971Alzheimer's disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs.Biochem Pharmacol2023https://conductscience.org/library/papers/36996971PubMed
629196460Microglia in Alzheimer's disease.J Cell Biol2018https://conductscience.org/library/papers/29196460PubMed
721037967CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.Hirosaki Igaku2010https://conductscience.org/library/papers/21037967PubMed
839684623Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis.Int J Mol Sci2024https://conductscience.org/library/papers/39684623PubMed
931894103Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET.Sci Transl Med2020https://conductscience.org/library/papers/31894103PubMed
1026011640Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1.J Clin Invest2015https://conductscience.org/library/papers/26011640PubMed
1131564456Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.Cell2019https://conductscience.org/library/papers/31564456PubMed
1225843029Repeating spatial activations in human entorhinal cortex.Curr Biol2015https://conductscience.org/library/papers/25843029PubMed
1334493616Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays.Neurology2021https://conductscience.org/library/papers/34493616PubMed
1432962744Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease.Mol Neurodegener2020https://conductscience.org/library/papers/32962744PubMed
1529154274Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.J Alzheimers Dis2018https://conductscience.org/library/papers/29154274PubMed
1639435008Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer's Disease.Br J Biomed Sci2024https://conductscience.org/library/papers/39435008PubMed
1740649044Erythrocyte Load in Cerebrospinal Fluid Linked with Hippocampal Atrophy in Alzheimer's Disease.J Clin Med2025https://conductscience.org/library/papers/40649044PubMed
1836927491Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications.Mol Neurodegener2023https://conductscience.org/library/papers/36927491PubMed
1935911597Iron and Alzheimer's Disease: From Pathology to Imaging.Front Hum Neurosci2022https://conductscience.org/library/papers/35911597PubMed
2023378859Nrf2 to pre-condition the brain against injury caused by products of hemolysis after ICH.Transl Stroke Res2013https://conductscience.org/library/papers/23378859PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/41008607/references